Literature DB >> 9179359

Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.

G Ribéreau-Gayon1, M L Jung, M Frantz, R Anton.   

Abstract

Cytotoxic effects of Viscum album L. (mistletoe) extracts and mistletoe lectins were studied by light and electron microscopy. The first events observed were membrane perforation and protrusions typical for apoptosis. Inhibition of Molt 4 cell growth was obtained with lectin concentrations in the pg/ml range as long as cells were cultured in serum-free medium. Under this condition, mistletoe lectin-III was about 10 times more cytotoxic than mistletoe lectin-I; mistletoe lectin-II was in between. Lectin cytotoxicity was modulated by human serum from donors who had never been treated with mistletoe preparations and lectin-specific carbohydrates, added at the mmol/l range, particularly D-galactose (or beta-lactose) for mistletoe lectin-I and N-acetyl-galactosamine for mistletoe lectin-II and -III. In addition, at subtoxic concentrations, mistletoe lectin-I, -II and -III enhanced the production of cytokines (tumour necrosis factor-alpha, interleukin-1 alpha) by isolated human monocytes. The experimental results are discussed in relation to the treatment of cancer patients administered with mistletoe extracts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179359     DOI: 10.1097/00001813-199704001-00002

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  12 in total

1.  Biological effects of natural and recombinant mistletoe lectin and an aqueous mistletoe extract on human monocytes and lymphocytes in vitro.

Authors:  U Elsässer-Beile; M Voss; R Schühle; U Wetterauer
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Pharmacokinetics of natural mistletoe lectins after subcutaneous injection.

Authors:  Roman Huber; Jürgen Eisenbraun; Barbara Miletzki; Michael Adler; Rainer Scheer; Reinhild Klein; Christoph H Gleiter
Journal:  Eur J Clin Pharmacol       Date:  2010-05-14       Impact factor: 2.953

Review 3.  [Use of phytopharmaceutical agents in dermatology. Indications, therapeutic approaches and side effects].

Authors:  S Meyer; T Vogt; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2005-05       Impact factor: 0.751

4.  Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2.

Authors:  E C Lavelle; G Grant; A Pusztai; U Pfüller; O Leavy; E McNeela; K H G Mills; D T O'Hagan
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia.

Authors:  C I Delebinski; S Jaeger; K Kemnitz-Hassanin; G Henze; H N Lode; G J Seifert
Journal:  Cell Prolif       Date:  2012-01-03       Impact factor: 6.831

6.  Induction of apoptosis and G2 /M cell cycle arrest by Scrophularia striata in a human leukaemia cell line.

Authors:  A Azadmehr; R Hajiaghaee; M Mazandarani
Journal:  Cell Prolif       Date:  2013-12       Impact factor: 6.831

7.  Unexpected different binding of mistletoe lectins from plant extracts to immobilized lactose and N-acetylgalactosamine.

Authors:  Tibor Hajtò; Fodor Krisztina; Aponyi Ildikò; Pallai Zsolt; Balogh Pèter; Németh Pèter; Perjési Pàl
Journal:  Anal Chem Insights       Date:  2007-09-17

8.  Apoptosis Cell Death Effect of Scrophularia Variegata on Breast Cancer Cells via Mitochondrial Intrinsic Pathway.

Authors:  Abbas Azadmehr; Reza Hajiaghaee; Behzad Baradaran; Hashem Haghdoost-Yazdi
Journal:  Adv Pharm Bull       Date:  2015-09-19

9.  [Paraoxonase 1 gene polymorphism 192Q/R in old men and long-livers from Tatars ethnic group].

Authors:  V V Pauk; I A Tuktarova; T R Nasibullin; L P Zueva; A Kh Adel'guzhina; E K Khusnutdinova; O E Mustafina
Journal:  Mol Biol (Mosk)       Date:  2007 Jul-Aug

10.  Transiently Expressed Mistletoe Lectin II in Nicotiana benthamiana Demonstrates Anticancer Activity In Vitro.

Authors:  Milena Mazalovska; J Calvin Kouokam
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.